Loading clinical trials...

Assessment on the Deep Remission Rate and Its Influencing Factors of Individualized Ustekinumab Therapy in Patients With Crohn's Disease | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT07600255

Assessment on the Deep Remission Rate and Its Influencing Factors of Individualized Ustekinumab Therapy in Patients With Crohn's Disease

In alignment with the STRIDE-II consensus, the therapeutic goal for Crohn's disease (CD) has shifted towards "deep remission," which necessitates both mucosal and transmural healing. Recognizing the l...

Lead sponsor: Second Affiliated Hospital of Wenzhou Medical University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Biologics for Stricturing Crohn's Diseases

NCT05645055 · The Efficacy of Biologics for Stricturing Crohn's Diseases

Not Yet RecruitingNA

The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children

NCT07424040 · Crohn's Diseases, Crohn's Disease in Pediatric Patient

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 20, 2026Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment156

Start dateJan 2021

Last updatedMay 20, 2026

Condition

Crohn's Diseases

Locations shown

The Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 20, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions